Table 4.
Model 1 | Model 2 | |||||
---|---|---|---|---|---|---|
Variable | n | Unadjusted OR (95% CI) | * Adjusted OR (95% CI) | Variable | Unadjusted OR (95% CI) | * Adjusted OR (95% CI) |
Etiology | Etiology | |||||
HCV | 952 | 1.0 | 1.0 | HCV | 1.0 | 1.0 |
NAFLD | 107 | 5.4 (3.4–8.5) | 3.9 (2.1–7.3) | Metabolic syndrome | 5.0 (3.1–7.8) | 3.4 (1.9–6.4) |
Alcohol abuse | 280 | 2.6 (1.8–3.8) | 2.5 (1.6–3.9) | Alcohol abuse | 2.6 (1.8–3.8) | 2.5 (1.5–3.9) |
HBV | 15 | 1.6 (0.4–7.1) | 1.3 (0.2–7.2) | HBV | 1.6 (0.4–7.1) | 1.3 (0.2–7.2) |
Idiopathic | 41 | 4.7 (2.4–9.5) | 3.6 (1.6–8.3) | Idiopathic | 6.0 (3.0–11.9) | 5.1 (2.2–11.7) |
Age | 139 5 | 1.0 (1.0–1.1) | 1.0 (1.0–1.1) | |||
Race | ||||||
White | 829 | 1.0 | 1.0 | |||
Black | 362 | 2.2 (1.5–3.4) | 2.2 (1.5–3.4) | |||
Hispanic | 172 | 0.4 (0.2–0.7) | 0.4 (0.2–0.7) | |||
Others | 32 | 0.9 (0.2–3.4) | 0.9 (0.2–3.4) | |||
BCLC Stage | ||||||
A | 188 | 1.0 | 1.0 | |||
B | 328 | 2.9 (1.4–5.8) | 2.9 (1.4–5.9) | |||
C | 527 | 2.5 (1.3–5.2) | 2.6 (1.3–5.2) | |||
D | 246 | 1.2 (0.5–2.9) | 1.2 (0.5–2.9) | |||
Unknown | 106 | 2.5 (1.0–6.0) | 2.5 (1.0–2.9) | |||
MELD score | ||||||
< 10 | 551 | 1.0 | 1.0 | |||
10–19.9 | 641 | 0.2 (0.1–0.3) | 0.2 (0.1–0.3) | |||
20+ | 73 | 0.1 (0.0–0.5) | 0.1 (0.0–0.5) | |||
Unknown | 130 | 0.7 (0.4–1.2) | 0.7 (0.4–1.3) | |||
AFP | ||||||
<20 | 516 | 1.0 | 1.0 | |||
20+ | 780 | 0.8 (0.5–1.2) | 0.8 (0.5–1.2) | |||
Unknown | 99 | 1.6 (0.9–2.8) | 1.6 (0.9–2.8) | |||
PVT | ||||||
Absent | 111 3 | 1.0 | 1.0 | |||
Present | 241 | 0.6 (0.3–1.1) | 0.6 (0.3–1.1) | |||
Unknown | 41 | 2.3 (1.1–4.9) |
Adjusted for age, race, BCLC stage, MELD score, AFP and portal vein thrombus